Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, Republic of Korea.
Department of Public Health and Welfare, The Graduate School, Konyang University, Daejeon, Republic of Korea.
Front Public Health. 2023 May 9;11:1167321. doi: 10.3389/fpubh.2023.1167321. eCollection 2023.
Prior to COVID-19 pandemic, a yearly upward trajectory in the number of chlamydia infection cases was observed in South Korea. However, in response to the COVID-19 pandemic, Korea implemented several public health and social measures, which were shown to have an impact on the epidemiology of other infectious diseases. This study aimed to estimate the impact of the COVID-19 pandemic on the incidence and number of reported chlamydia infections in South Korea.
Using the monthly number of reported chlamydia infection data between 2017 and 2022, we compared the trends in the reported numbers, and the incidence rates (IR) of chlamydia infection stratified by demographic characteristics (sex, age group, and region) in the pre- and during COVID-19 pandemic period (January 2017-December 2019 and January 2020-December 2022).
We observed an irregular downward trajectory in the number of chlamydia infection in the during-pandemic period. A 30% decrease in the total number of chlamydia infection was estimated in the during-pandemic compared to the pre-pandemic period, with the decrease greater among males (35%) than females (25%). In addition, there was a decrease in the cumulative incidence rate of the during COVID-19 pandemic period (IR: 0.43; 95% CI: 0.42-0.44) compared to the pre-pandemic period (IR: 0.60; 95% CI: 0.59-0.61).
We identified decrease in the number of chlamydia infection during COVID-19 pandemic which is likely due to underdiagnosis and underreporting for the infection. Therefore, strengthening surveillance for sexually transmitted infections including chlamydia is warranted for an effective and timely response in case of an unexpected rebound in the number of the infections.
在 COVID-19 大流行之前,韩国每年的衣原体感染病例数量呈上升趋势。然而,为应对 COVID-19 大流行,韩国实施了多项公共卫生和社会措施,这些措施对其他传染病的流行病学产生了影响。本研究旨在评估 COVID-19 大流行对韩国衣原体感染发病率和报告病例数的影响。
使用 2017 年至 2022 年月报报告的衣原体感染病例数据,我们比较了大流行前后(2017 年 1 月至 2019 年 12 月和 2020 年 1 月至 2022 年 12 月)报告数量和衣原体感染发病率(IR)的趋势,并按人口统计学特征(性别、年龄组和地区)对其进行分层。
我们观察到在大流行期间衣原体感染数量呈不规则下降趋势。与大流行前相比,大流行期间衣原体感染总数估计减少了 30%,其中男性(35%)的降幅大于女性(25%)。此外,与大流行前相比,COVID-19 大流行期间累积发病率(IR:0.43;95%CI:0.42-0.44)下降(IR:0.60;95%CI:0.59-0.61)。
我们发现 COVID-19 大流行期间衣原体感染数量减少,这可能是由于感染的诊断和报告不足。因此,需要加强对性传播感染(包括衣原体)的监测,以便在感染数量意外反弹时做出有效和及时的反应。